Patients Must Have H3 K27M Tumor Mutation for Clinical Trial with ONC201 - 102191

Spotlight
Video

Patients Must Have H3 K27M Tumor Mutation for Clinical Trial with ONC201

Cancer-News has 111 videos Subscribe Here

Loading........
Description: Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How Patients Must Have H3 K27M Tumor Mutation for Clinical Trial with ONC201. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Shared By : Cancer-News
Posted on : 03/20/18
Added : 5 months ago
Category : Brain Cancer



Recommended

Nothing found.